| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/19/1998 | WO1998006862A1 Methods for producing carotenoid compounds and speciality oils in plant seeds |
| 02/19/1998 | WO1998006861A2 Delivery of tolerogenic antigens via edible plants or plant-derived products |
| 02/19/1998 | WO1998006860A1 Peptide with inhibitory activity towards plant pathogenic fungi |
| 02/19/1998 | WO1998006859A1 Human chitinase alpha and chitinase alpha-2 |
| 02/19/1998 | WO1998006858A1 BETA-1,4-ENDOGLUCANASE FROM $i(ASPERGILLUS NIGER) |
| 02/19/1998 | WO1998006857A1 Plant tissue treatment composition |
| 02/19/1998 | WO1998006856A1 Phytase from bacillus subtilis, gene encoding said phytase, method for its production and use |
| 02/19/1998 | WO1998006855A1 Compositions and methods for delivery of nucleic acids to hepatocytes |
| 02/19/1998 | WO1998006854A1 Dna sequence useful for the production of polyhydroxyalkanoates |
| 02/19/1998 | WO1998006853A1 Treatment and prevention of helicobacter infection |
| 02/19/1998 | WO1998006852A1 Purified proteins, recombinant dna sequences and processes for controlling the ripening of coffee plants |
| 02/19/1998 | WO1998006851A2 DEFINING EPITOPES OF THE OUTER MEMBRANE PROTEIN CopB OF $i(MORAXELLA CATARRHALIS) |
| 02/19/1998 | WO1998006850A1 Immunologically active proteins of borrelia burgdorferi, coded nuclein acids of such and their use in test kits and vaccines |
| 02/19/1998 | WO1998006849A1 Expression vectors, cells, and methods for preparing thrombopoietin polypeptides |
| 02/19/1998 | WO1998006848A1 GnRH-LEUKOTOXIN CHIMERAS |
| 02/19/1998 | WO1998006847A1 Human dbi/acbp-like protein |
| 02/19/1998 | WO1998006846A1 Human induced tumor protein |
| 02/19/1998 | WO1998006845A1 Mammalian ribonuclease inhibitors and use thereof |
| 02/19/1998 | WO1998006844A1 Keratinocyte growth factor-2 (kgf-2 or fibroblast growth factor-12, kgf-12) |
| 02/19/1998 | WO1998006843A1 Neuritin, a neurogene |
| 02/19/1998 | WO1998006842A1 Mammalian cell surface antigens; related reagents |
| 02/19/1998 | WO1998006841A2 Two human nsp-like proteins |
| 02/19/1998 | WO1998006840A1 Novel human glycoprotein |
| 02/19/1998 | WO1998006839A1 Cd44-like protein |
| 02/19/1998 | WO1998006838A1 Methods and means for modifying complement activation |
| 02/19/1998 | WO1998006837A1 Phenotypic conversion of drug-resistant bacteria to drug-sensitivity |
| 02/19/1998 | WO1998006836A2 Expression system derived from the lipase regulation cascade of pseudomonas alcaligenes |
| 02/19/1998 | WO1998006835A2 Modifying insect cell gylcosylation pathways with baculovirus expression vectors |
| 02/19/1998 | WO1998006834A1 Process for developing mammals with definite genetic features |
| 02/19/1998 | WO1998006832A1 Protopectinase |
| 02/19/1998 | WO1998006831A1 Transgenic plant cells and plants with modified acetyl-coa formation |
| 02/19/1998 | WO1998006830A1 Synthetic polynucleotides |
| 02/19/1998 | WO1998006828A1 Phage bonded to nuclear location signal |
| 02/19/1998 | WO1998006827A2 Method for immortalizing cells |
| 02/19/1998 | WO1998006824A1 Immortalized cell lines for virus growth |
| 02/19/1998 | WO1998006750A2 Resistance against nematodes and/or aphids |
| 02/19/1998 | WO1998006749A2 Soluble monovalent and multivalent mhc class ii fusion proteins, and uses therefor |
| 02/19/1998 | WO1998006748A1 Acquired resistance npr genes and uses thereof |
| 02/19/1998 | WO1998006747A2 Uses for wnt polypeptides |
| 02/19/1998 | WO1998006737A1 Long wavelength engineered fluorescent proteins |
| 02/19/1998 | WO1998006736A1 Stable compositions for nucleic acid amplification and sequencing |
| 02/19/1998 | WO1998006735A1 Modified acyl-acp desaturase |
| 02/19/1998 | WO1998006734A1 Novel prokaryotic polynucleotides, polypeptides and their uses |
| 02/19/1998 | WO1998006733A1 Nucleotide sequence encoding the cd33-like protein |
| 02/19/1998 | WO1998006732A1 Propargylethoxyamino nucleotides |
| 02/19/1998 | WO1998006440A2 Phenotypic conversion of cells mediated by external guide sequences |
| 02/19/1998 | WO1998006437A2 Compositions and methods for polynucleotide delivery |
| 02/19/1998 | WO1998006431A2 Method for treating diabetes |
| 02/19/1998 | WO1998006429A1 Hiv p-17 peptide fragment, compositions containing and methods for producing and using same |
| 02/19/1998 | WO1998006428A1 Mucosal immunogens for novel vaccines |
| 02/19/1998 | WO1998006420A1 Bone morphogenetic protein and fibroblast growth factor compositions and methods for the induction of cardiogenesis |
| 02/19/1998 | WO1998006408A1 Methods and compositions for preventing or retarding the development of atherosclerotic lesions |
| 02/19/1998 | WO1998006263A1 Programmed cell death and ich-3 |
| 02/19/1998 | WO1998006248A2 HUMANIZED IMMUNOGLOBULIN REACTIVE WITH α4β7 INTEGRIN |
| 02/19/1998 | WO1998002567A3 PROCESS FOR THE PREPARATION OF CEPHALOSPORINS USING $i(ACREMONIUM CHRYSOGENUM) |
| 02/19/1998 | WO1998002560A3 Genomic sequence of rhizobium sp. ngr 234 symbiotic plasmid |
| 02/19/1998 | WO1998002036A3 Animal model knock-out for a neuronal intermediate filament protein |
| 02/19/1998 | WO1998001571A3 Erythromycins and process for their preparation |
| 02/19/1998 | WO1998001568A3 Method of preparing (s) - or (r) -3,3,3-trifluoro-2-hydroxy-2- methylpropionic acid |
| 02/19/1998 | WO1997049805A3 Recognition molecules interacting specifically with the active site or cleft of a target molecule |
| 02/19/1998 | WO1997048799A3 Polynucleotides from human fetal brain encoding secreted proteins |
| 02/19/1998 | WO1997046569A3 2'-substituted nucleosides and oligonucleotide derivatives |
| 02/19/1998 | WO1997044451A3 Vasoactive amine binding molecules |
| 02/19/1998 | WO1997044356A3 Ret ligand (retl) for stimulating neural and renal growth |
| 02/19/1998 | WO1997043617A3 Method for dissociating biotin complexes |
| 02/19/1998 | WO1997041243A3 A cytoplasmic gene expression system which utilizes a prokaryotic rna polymerase autogene |
| 02/19/1998 | WO1997039120A3 Antisense inhibitors of vascular endothelial growth factor (vefg/vpf) expression |
| 02/19/1998 | WO1997038085A3 Genes amplified in cancer cells |
| 02/19/1998 | WO1997037024A3 Antifungal polypeptide and methods for controlling plant pathogenic fungi |
| 02/19/1998 | DE19707497A1 Reaktionsbeutelvorrichtung zur Durchführung von mehrstufigen Kultivierungs/Separations-Vorgängen und/oder Reaktionen Reaction bag apparatus for performing multi-step culturing / separation processes and / or reactions |
| 02/19/1998 | DE19632862A1 Immunologisch aktive Proteine von Borrelia burgdorferi, dafür kodierende Nukleinsäuren sowie deren Verwendung in Testkits und als Impfstoffe Immunologically active proteins of Borrelia burgdorferi, nucleic acids coding therefor and the use thereof in test kits and as vaccines |
| 02/19/1998 | DE19632532A1 Verfahren zur Herstellung von Säugetieren mit definierten genetischen Eigenschaften Process for the preparation of mammals with defined genetic properties |
| 02/19/1998 | CA2263792A1 Phytase from bacillus subtilis, gene encoding said phytase, method for its production and use |
| 02/19/1998 | CA2263730A1 Delivery of tolerogenic antigens via edible plants or plant-derived products |
| 02/19/1998 | CA2263706A1 Spatial and temporal control of gene expression using a heat shock protein promoter in combination with local heat |
| 02/19/1998 | CA2263316A1 Methods and compositions for preventing or retarding the development of atherosclerotic lesions |
| 02/19/1998 | CA2263310A1 In vitro assay for carcinogens using phenotypic transformation of human cells |
| 02/19/1998 | CA2263219A1 Methods and means for modifying complement activation |
| 02/19/1998 | CA2263195A1 Soluble monovalent and multivalent mhc class ii fusion proteins, and uses therefor |
| 02/19/1998 | CA2263186A1 Transgenic plant cells and plants with modified acetyl-coa formation |
| 02/19/1998 | CA2263172A1 Two human nsp-like proteins |
| 02/19/1998 | CA2263169A1 Human dbi/acbp-like protein |
| 02/19/1998 | CA2263165A1 Human induced tumor protein |
| 02/19/1998 | CA2263146A1 Acquired resistance npr genes and uses thereof |
| 02/19/1998 | CA2263143A1 Keratinocyte growth factor-2 (kgf-2 or fibroblast growth factor-12, fgf-12) |
| 02/19/1998 | CA2262748A1 Defining epitopes of the outer membrane protein copb of moraxella catarrhalis |
| 02/19/1998 | CA2262529A1 Phage bonded to nuclear location signal |
| 02/19/1998 | CA2262527A1 Method for removing amplification inhibitors from test samples |
| 02/19/1998 | CA2262524A1 Gnrh-leukotoxin chimeras |
| 02/19/1998 | CA2262507A1 Expression vectors, cells, and methods for preparing thrombopoietin polypeptides |
| 02/19/1998 | CA2262432A1 Hiv p-17 peptide fragment, compositions containing and methods for producing and using same |
| 02/19/1998 | CA2262429A1 Peptide with inhibitory activity towards plant pathogenic fungi |
| 02/19/1998 | CA2262422A1 Programmed cell death and ich-3 |
| 02/19/1998 | CA2261577A1 Methods for producing carotenoid compounds and speciality oils in plant seeds |
| 02/19/1998 | CA2261572A1 Lysyl oxidase synthetic polynucleotides |
| 02/18/1998 | EP0824150A2 Plant promoter and utilization thereof |
| 02/18/1998 | EP0824149A2 Glutamine: fructose-6-phosphate amidotransferase (GFAT), its production and use |
| 02/18/1998 | EP0824148A2 Polyester synthase gene and process for producing polyester |
| 02/18/1998 | EP0823942A1 Efflux pump inhibitors |
| 02/18/1998 | EP0823941A1 Human antibodies derived from immunized xenomice |